Amgen Guides FY2015 Revenues $16-$18B; Adj. EPS of $7.25-$8.60; Authorized to Repurchase $5B in Amgen Shares (AMGN)

by Benzinga Staff
April 21, 2011 9:04 AM | 7 seconds read |
Amgen AMGN Guides FY2015 Revenues $16-$18B; Adj. EPS of $7.25-$8.60; Authorized to Repurchase $5B in Amgen Shares.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsGuidanceBuybacksBiotechnologyHealth Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved